Blood Pressure and Cholesterol Control in Hypertensive Hypercholesterolemic Patients: National Health and Nutrition Examination Surveys 1988–2010

Cited by (149)

Items 101–149 of 149

1. The Current Situation of Hypertension among Rural Minimal Assurance Family Participants in Liaoning (China): A Cross-Sectional Study
   Yintao Chen, Shasha Yu, Shuang Chen, Xiaofan Guo, Yuan Li, Li Zhao, Yingxian Sun · 2016 · International Journal of Environmental Research and Public Health
2. Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
   Zhanna D. Kobalava, Е. В. Кохан · 2020 · Rational Pharmacotherapy in Cardiology
3. Efficacy and Safety of Coadministered Ezetimibe–Rosuvastatin plus Telmisartan in South Korean Patients with Dyslipidemia and Hypertension: A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase III Trial
   Zhao Yan Song, Moo Hyun Kim, Hancheol Lee, Sung‐Ji Park, Moo‐Yong Rhee, Jong‐Il Choi, Sang‐Hyun Kim, In‐Ho Chae, Young‐Joon Hong, Namho Lee et al. · 2023 · Journal of Clinical Medicine
4. Comparison between Negative T waves characteristics in acute coronary syndrome and pulmonary embolism
   Elnaz Javanshir, Samad Ghaffari, Reza Hajizadeh, Hanieh Sakha, Sahar Ghodratizadeh, Hadiseh Kavandi · 2018 · Journal of Electrocardiology
5. Calming down chaos regarding redefining blood pressure targets-the importance of statin-based therapy
   Kwang Kon Koh, Seung Hwan Han, Ichiro Sakuma, Dong Hui Zhao · 2016 · International Journal of Cardiology
6. Opportunities for multidisciplinary ASH clinical hypertension specialists in an era of population health and accountable care: ASH leadership message
   Brent M. Egan · 2014 · Journal of the American Society of Hypertension
7. Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)
   Benjamin Bouillet, Romain Boulestreau, Victor Aboyans, Sophie Béliard, Franck Boccara, Bertrand Cariou, Sybil Charrière, Philippe Moulin, Bruno L Vergès, René Valéro et al. · 2026 · Archives of cardiovascular diseases
8. Combination of Lipid-Lowering Agents with Antihypertensive Drugs: A Joint Fight Against the Two Most Important Risk Factors?
   Yanglu Zhao, Nathan D. Wong · 2015 · Springer eBooks
9. Factors affecting patient retention to hypertension treatment in a North Indian State: A mixed‐method study
   Nidhi Jaswal, Sonu Goel, Kritika Upadhyay, Anupam Khungar Pathni, Om Prakash Bera, Vandana Shah · 2024 · Journal of Clinical Hypertension
10. Synergistic effects of drug and aerobic exercise on endothelial function and epicardial fat thickness in patients with hypertension and dyslipidemia
    Eun‐Ah Jo, Shanshan Wu, Hyung-Rae Han, Jung-Jun Park, Jung Ho Heo · 2025 · Kosin Medical Journal
11. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
    Woo Youl Kang, Sook Jin Seong, Boram Ohk, Mi‐Ri Gwon, Bo Kyung Kim, Seungil Cho, Wang-Seob Shim, Kyung‐Tae Lee, Eun Hee Kim, Dong Heon Yang et al. · 2018 · Drug Design Development and Therapy
12. Prebiotics and Probiotics as Functional Foods: Prospect and Promises in Metabolic Diseases
    Tanuka Das, Tandrani Das, Goutam Ghosh · 2022 · Springer eBooks
13. Association of baseline serum cholesterol with benefits of intensive blood pressure control
    Xiaoqi Wang, Yingqing Feng, Li Yang, Guohui Zhang, Xiaoyuan Tian, Qianhui Ling, Jiang‐Shan Tan, Jun Cai · 2023 · Chinese Medical Journal
14. Effectiveness of a Tailored Behavioral Intervention to Improve Hypertension Control
    Brent M. Egan · 2014 · Hypertension
15. Combination therapy with perindopril and atorvastatin - an effective method to reduce cardiovascular risk in patients with hypertension and dyslipidaemia
    Miroslav Souček, Jan Novák · 2020 · Medicína pro praxi
16. Secondary (acquired) hypercholesterolemia
    Arrigo F.G. Cicero, Raffaele Ivan Cincione · 2022 · Elsevier eBooks
17. Clinical Patterns of Dyslipidemia in Patients With Initial-Treatment and Drug-Naïve Schizophrenia
    Zhaopeng Kang, Lin Zhang, Tao Jiang, Guangya Zhang · 2025 · ALPHA PSYCHIATRY
18. Height May Explain Sex Differences in Systolic Blood Pressure in Older Adults
    Brent M. Egan, Jiexiang Li, Susan E. Sutherland, Benjamin Riesser, Holly J. Mattix-Kramer, Michael Rakotz · 2025 · Hypertension
19. Real-world characterization of clinical management and achievement of the recommended risk-based low-density lipoprotein cholesterol and blood pressure goals in patients with arterial hypertension and dyslipidemia. The SNAPSHOT study
    José María Mostaza, Miguel Camafort, Soraya Sotto Rodriguez, Cristina Vehi Gasol, Juan Carlos Yáñez Wonenburguer, Miguel Chopo Alcubilla, Carlos Escobar, María Luisa Fernández Bujía, Fernando Gallo Trébol, Mar Gracia et al. · 2025 · Clínica e Investigación en Arteriosclerosis (English Edition)
20. Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society (NSFA) and the French Society of Cardiology (SFC)
    Benjamin Bouillet, Romain Boulestreau, Victor Aboyans, Sophie Béliard, Franck Boccara, Bertrand Cariou, Sybil Charrière, Philippe Moulin, Bruno L Vergès, René Valéro et al. · 2026 · Diabetes & Metabolism
21. Characterization of diabetes risk factors in patients prescribed chronic statin therapy
    William M. King, Joseph J. Saseen, Sarah L. Anderson · 2014 · Therapeutic Advances in Chronic Disease
22. Hypertonie und Dyslipidämie
    Roland Erich Schmieder · 2017 · Die Gastroenterologie
23. The impact of dyslipidemia and hyperhomocysteinemia on the development of arterial hypertension
    Sonja Smiljić, Aleksandra Ilić · 2024 · Galenika Medical Journal
24. The effect of a new combined feed on some physiological parameters of laboratory rats
    Yurii Boiko, И. А. Бойко · 2024 · BIO Web of Conferences
25. Triple Therapy with Telmisartan, Amlodipine, and Rosuvastatin (TAR) Versus Telmisartan/Amlodipine (TA) and Telmisartan/Rosuvastatin (TR) Combinations in Hypertension and Dyslipidemia: A Systematic Review and Meta-analysis
    Shady Habboush, Navyamani Venkata Durga Kagita, Ahmed Farid Gadelmawla, Ahmed Elmoursi, Nooraldin Merza, Ahmed Ali Faheem Abdo, Alhussein Mostafa Zahran, Moustafa Eldeib, Alsayed Ali Almarghany, Mohamed M Abdelfadil et al. · 2024 · High Blood Pressure & Cardiovascular Prevention
26. Effect of Hypertension and Hypercholesterolemia on Auditory Brainstem Response in Adults
    Sagarika Bhattacharjee, Mansi Mondol, RajanKashyap · 2016 · International journal of medical and health sciences
27. Control and Prevention American Heart Association, the American College of Cardiology, and the Centers for Disease An Effective Approach to High Blood Pressure Control: A Science Advisory From the
    Kim Allan Williams Sr, Eduardo Sánchez, Alan S. Go, M. Leon Bauman, Sallyann M. Coleman King, Gregg C. Fonarow, Willie Lawrence · 2013
28. Comparative impact of implementing the 2013 or 2014 cholesterol guideline on vascular events in a quality improvement network
    Brent M. Egan, Susan E. Sutherland, William F. Childers, Ruthanne M. Dahlheimer, George A. Helmrich, Daryl A. Lapeyrolerie, Nancy Markle, Dennis W. Murphy, Locke Simmons, Robert A. Davis et al. · 2016 · Therapeutic Advances in Cardiovascular Disease
29. Патоґенетичні особливості артеріальної гіпертензії у хворих із нормальною, підвищеною та недостатньою масою тіла
    В. К. Тащук, Г. І. Хребтій, Omer Muhammad Khuda Bakhsh, Aissaoui Anis · 2015 · Lviv clinical bulletin
30. Smanjenje tereta koronarne bolesti srca na dokazima utemeljenim principima lijeËenja Evidence-based treatment approaches in reducing the burden of coronary heart disease
    Veronika Hribar, Sanja Brus · 2014
31. Lipertance - jeden krok v léčbě kardiovaskulárního rizika, aneb nikdy to nebylo jednodušší
    Zuzana Zafarová · 2016 · Cor et Vasa
32. The influence of omega-3 polynenasic fatty acids on the pathogenetic lines of arterial hypertension in the person with abdominal obesity
    L.І. Vlasyk, V.K. Taschuk, Halyna I. Khrebtii · 2019 · One Health and Nutrition Problems of Ukraine
33. Uncontrolled Hypertension and its Contributing Factors in a Tertiary Care Hospital of Lahore, Pakistan.
    Omer Sabir, Anam Rashid, Muhammad Mohsin Riaz · 2021 · Pakistan Journal of Kidney Diseases
34. The Surgical Rehabilitation of the Amputee.
    John V. Basmajian · 1980 · Europe PMC (PubMed Central)
35. Formulation and evaluation of selexipag and ezetimibe bi-layer tablet by novel approach
    Satpute Vivek Mahavir, Punit R. Rachh · 2022 · International Journal of Health Sciences
36. Circulation : 2013 Editors’ Picks: Part II
    The Editors · 2014 · Circulation
37. Lowering Effect of Potassium on Hypertension
    Maryam Hafeez, Aqsa Riaz, Azeem Azam, Marina Sajid, Hamza Faseeh, Farhan Anjum, Tanzeela Rubab, Shanza Aziz, Maryam Latif · 2023 · Pakistan Journal of Health Sciences
38. Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults
    Brent M. Egan, Jiexiang Li, Susan E. Sutherland, Michael Rakotz · 2024 · Journal of Hypertension
39. The Effect of Food on the Incident of Hypertension
    Restia Restia, Yusra Pintaningrum, Cut Warnaini · 2023 · JURNAL BIOLOGI TROPIS
40. RETRACTED: Applying spectral analysis to the arterial pulse to discriminate cardiovascular side effects following administration of Moderna's mRNA-1273 vaccine
    Chun‐Chao Chen, Wen-Ting Chang, Chun-Chih Chiu, Tsung-Yeh Yang, Wen‐Rui Hao, Tzu-Wei Huang, Kuan-Jie Lin, Yu-Ann Fang, Min‐Huei Hsu, Tsung‐Lin Yang et al. · 2025 · European Journal of Pharmacology · Retracted
41. Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Society of Atherosclerosis (NSFA) and the French Society of Cardiology (SFC)
    Benjamin Bouillet, Romain Boulestreau, Victor Aboyans, Sophie Béliard, Franck Boccara, Bertrand Cariou, Sybil Charrière, Philippe Moulin, Bruno L Vergès, René Valéro et al. · 2025 · Annales d Endocrinologie
42. Prevalence, Associate Health Conditions and Evolution of Chronic Hypertension Among Pregnant Women in Abidjan’s Neighborhood
    Koussoh Simone Malik, Marie-Laure Tiadé, Guanga David Meless, Franck-Renaud Djedjro Meless, Kouamé Koffi, Julie Sackou-Kouakou, Kassi Anicet Adoubi, Agbaya Serge Oga, Odile Aké · 2025 · International Journal of Public Health
43. Probiotic therapy for heart failure: Investigating the potential anti-hypertrophic properties of probiotics
    Grace Ettinger · 2014 · Scholarship@Western (Western University)
44. Does hypercholesterolemia worsen cognitive decline in arterial hypertension? Insights from clinical and experimental studies
    Andressa Betat, Viviane dos Santos, Cláudio Gabriel Aguiar de Oliveira, Lais Alflen, Charles Francisco Ferreira, Geison Souza Izídio, Renata Maria Lataro · 2026 · Journal of Hypertension
45. Nouvelles fonctions de l'enzyme de conversion de l'angiotensine et du récepteur de la (pro)rénine en pathologies cardiovasculaires et neurologiques
    Jeanne d’Arc Al Bacha · 2015
46. Role of prognostic markers in the pathogenesis of hypertension
    Saira Rafaqat · 2026 · World Journal of Hypertension
47. Bayesian binary quantile regression adaptive Lasso for modelling hypertension: a bootstrap based consistency analysis
    Lilis Harianti Hasibuan, Ferra Yanuar, Dodi Devianto, Maiyastri - · 2026 · Communications in Statistics Case Studies Data Analysis and Applications
48. Blood Pressure and Hypertension Among Adults Aged 80 and Above: Findings From the Population‐Based German Health Survey Gesundheit 65+
    Dorothea Möẞnang, Julia Charlotte Büschges, Giselle Sarganas, Beate Gaertner, Judith Fuchs, Hannelore K. Neuhauser · 2026 · International Journal of Hypertension
49. Clinical inertia in cardiovascular risk management: prevalence, associated factors, and impact on outcomes of the OPM study
    José Abellán Alemán, Pablo Sánchez-Rubio Lezcano, D. Pardo, L. Guerra, Rafael Crespo Sabarís, G. Portillo, Begoña Rincón Ruiz, Gloria Antón Pérez, J. I. Iriso, Pilar Segura et al. · 2026 · Journal of Global Health